tiprankstipranks
Kriti Nutrients Limited (IN:KRITINUT)
:KRITINUT
India Market
Want to see IN:KRITINUT full AI Analyst Report?

Kriti Nutrients Limited (KRITINUT) AI Stock Analysis

0 Followers

Top Page

IN:KRITINUT

Kriti Nutrients Limited

(KRITINUT)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 5.2)
Rating:74Outperform
Price Target:
₹110.00
▲(39.95% Upside)
Action:ReiteratedDate:04/21/26
The score is driven primarily by solid financial strength—especially the very low leverage and strong equity backing—alongside steady revenue growth. Valuation is supportive with a low P/E, while the main offsets are weaker cash-flow trends and stretched technical momentum signals (high RSI/Stoch) that raise near-term pullback risk.
Positive Factors
Balance sheet strength
Extremely low leverage and high equity backing provide durable financial flexibility. With debt-to-equity at 0.01 and solid ROE, the company can fund working-capital swings, invest in capacity, and withstand commodity cycles without needing frequent external financing, lowering structural risk.
Negative Factors
Eroding net profitability
A falling net margin signals rising input or operating costs, weaker pricing power, or mix shifts. This compresses retained earnings and reduces capacity to reinvest or build cash buffers, making sustained returns and dividend capacity more uncertain absent margin restoration.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Extremely low leverage and high equity backing provide durable financial flexibility. With debt-to-equity at 0.01 and solid ROE, the company can fund working-capital swings, invest in capacity, and withstand commodity cycles without needing frequent external financing, lowering structural risk.
Read all positive factors

Kriti Nutrients Limited (KRITINUT) vs. iShares MSCI India ETF (INDA)

Kriti Nutrients Limited Business Overview & Revenue Model

Company Description
Kriti Nutrients Limited engages in the manufacture and sale of soyabean seeds under the Kriti brand in India and internationally. It offers edible oils, such as refined sunflower oil, soya bean oil, filtered groundnut oil, and mustard oil; soya le...
How the Company Makes Money
Kriti Nutrients Limited primarily makes money by processing agricultural oilseeds and selling the resulting outputs across multiple product streams: (1) Edible oils: revenue is generated from selling refined and/or processed edible oils to wholesa...

Kriti Nutrients Limited Financial Statement Overview

Summary
Stable revenue growth (+7.47% from 2024 to 2025) and a very strong balance sheet (debt-to-equity 0.01; equity ratio 89.06%; ROE 17.46%) support the score. Offsetting factors are weaker profitability (net margin down to 5.03% from 6.63%) and pressured cash generation (free cash flow growth declined; FCF to net income 0.74).
Income Statement
72
Positive
Balance Sheet
78
Positive
Cash Flow
65
Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue8.15B7.34B6.83B7.96B7.51B6.90B
Gross Profit890.11M1.03B1.07B780.37M679.84M378.97M
EBITDA486.40M557.89M666.67M356.28M222.83M242.58M
Net Income315.50M369.94M452.87M207.98M123.05M150.57M
Balance Sheet
Total Assets2.56B2.38B2.09B1.93B1.68B1.24B
Cash, Cash Equivalents and Short-Term Investments521.26M265.85M210.43M190.38M37.16M30.21M
Total Debt59.08M30.69M121.45M403.73M375.58M35.38M
Total Liabilities271.89M259.39M325.25M607.00M554.76M232.38M
Stockholders Equity2.29B2.12B1.76B1.32B1.13B1.01B
Cash Flow
Free Cash Flow397.30M273.10M409.62M133.43M-193.72M38.16M
Operating Cash Flow427.15M319.58M498.13M198.61M-105.10M90.22M
Investing Cash Flow-321.63M-288.64M-291.87M-31.35M-199.81M11.95M
Financing Cash Flow13.72M-106.49M-304.01M-14.05M311.86M-72.13M

Kriti Nutrients Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price78.60
Price Trends
50DMA
67.84
Positive
100DMA
70.56
Positive
200DMA
83.20
Positive
Market Momentum
MACD
2.71
Negative
RSI
74.82
Negative
STOCH
82.46
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRITINUT, the sentiment is Positive. The current price of 78.6 is above the 20-day moving average (MA) of 65.15, above the 50-day MA of 67.84, and below the 200-day MA of 83.20, indicating a bullish trend. The MACD of 2.71 indicates Negative momentum. The RSI at 74.82 is Negative, neither overbought nor oversold. The STOCH value of 82.46 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:KRITINUT.

Kriti Nutrients Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
₹66.73B17.0229.46%24.08%
74
Outperform
₹4.86B9.380.43%22.61%-20.50%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
₹7.20B7.5964.53%-25.13%
59
Neutral
₹1.99B39.8172.12%-25.75%
54
Neutral
₹3.90B18.0317.22%90.29%
44
Neutral
₹1.30B15.5726.18%260.80%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:KRITINUT
Kriti Nutrients Limited
100.11
3.79
3.93%
IN:GOKUL
Gokul Refoils & Solvent Ltd.
40.50
-5.14
-11.26%
IN:GOKULAGRO
Gokul Agro Resources Ltd.
226.25
105.85
87.92%
IN:MKPL
M K Proteins Limited
5.33
-1.29
-19.49%
IN:MUKKA
Mukka Proteins Limited
24.30
-8.03
-24.84%
IN:ROML
Raj Oil Mills Limited
45.02
-0.68
-1.49%

Kriti Nutrients Limited Corporate Events

Kriti Nutrients updates Memorandum of Association after EGM approval
Mar 23, 2026
Kriti Nutrients Limited has notified the stock exchanges that shareholders approved and adopted a revised Memorandum of Association at an Extraordinary General Meeting held on 20 March 2026 in Indore. The amendment includes the insertion of a new ...
Kriti Nutrients Updates Articles of Association After Shareholder Approval
Mar 23, 2026
Kriti Nutrients Limited has notified the stock exchanges that shareholders approved and adopted a new set of Articles of Association at an Extraordinary General Meeting held on 20 March 2026. The changes include the insertion of a new Article 92 a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 21, 2026